logotype
  • Home
  • About Us
  • Events
    • Upcoming Conferences
    • Past Conferences
  • Event Support
  • Careers
  • Contact Us
logotype
  • Home
  • About Us
  • Events
    • Upcoming Conferences
    • Past Conferences
  • Event Support
  • Careers
  • Contact Us
  • Home
  • About Us
  • Events
    • Upcoming Conferences
    • Past Conferences
  • Event Support
  • Careers
  • Contact Us
logotype
logotype
  • Home
  • About Us
  • Events
    • Upcoming Conferences
    • Past Conferences
  • Event Support
  • Careers
  • Contact Us

Tag: Counterfeit

September 6, 2023
by info@virtueinsight.comNews

Danaher agrees to acquire UK’s Abcam for $5.7bn

  Global science and technology provider Danaher has signed a definitive agreement for the acquisition of all outstanding stakes in UK-based protein consumables supplier Abcam in a deal valued at $5.7bn. Under the terms of the agreement, Danaher will acquire all the outstanding...
read more
September 6, 2023
by info@virtueinsight.comNews

Bruker to buy PhenomeX for $108M

    Scientific instruments maker Bruker has agreed to buy PhenomeX for about $108 million, marking its entry into the market for functional single-cell biology research systems. PhenomeX supplies an analysis platform that enables researchers to characterize tens of...
read more
September 6, 2023
by info@virtueinsight.comNews

Revolution Medicines, Inc. to Acquire EQRx, Inc.

  Revolution Medicines, Inc.  a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, and EQRx, Inc. today announced a definitive agreement through which Revolution Medicines plans to acquire EQRx in an all-stock transaction intended to add more...
read more
August 7, 2023
by info@virtueinsight.comNews

BioNTech Finalizes Acquisition of InstaDeep for $549M

  BioNTech has officially completed the acquisition of InstaDeep Ltd.—a technology company in the artificial intelligence (AI) and machine learning (ML) space— for approximately $549 million.  The takeover follows a collaboration between the two parties since 2019 and an equity...
read more
August 7, 2023
by info@virtueinsight.comNews

Biogen to Buy Reata for $7.3 Billion in Rare-Disease Deal

Biogen agreed to give $172.50 per share in cash to Reata, accompanied by term debt issuance. The transaction will close in the fourth quarter of 2023. Biogen’s president and chief executive officer, Christopher Viehbacher, said the company believes it has the foundation in place to...
read more
August 7, 2023
by info@virtueinsight.comNews

Carmell to merge with regenerative medicine company Axolotl

    Regenerative medicine company, Carmell Therapeutics, announced the execution of a definitive agreement and plan of merger (the “Merger Agreement”) with Flagstaff-based Axolotl Biologix. Axolotl develops, designs, and sells products that are human amnion-based, for...
read more
August 7, 2023
by info@virtueinsight.comNews

Quince Therapeutics To Acquire EryDel

    Quince Therapeutics (Nasdaq: QNCX) in its agreement to acquire EryDel SpA in a stock-for-stock upfront exchange and potential downstream milestone cash payments. Quince Therapeutics is a biotechnology company focused on acquiring, developing, and commercializing...
read more
July 1, 2023
by info@virtueinsight.comNews

Advanco Acquires Vantage Consulting Group

Advanco, established as a global pharmaceutical and life sciences track and trace solutions provider, has announced the acquisition of manufacturing automation specialist Vantage Consulting Group. The company will continue to be called advanco, with an enlarged client portfolio of...
read more
July 1, 2023
by info@virtueinsight.comNews

TraceLink and PharmaLink Partner Up on Simplifying DSCSA Compliance Process

TraceLink, a leading digital network platform company enabling end-to-end product orchestration, has announced a partnership with PharmaLink. TraceLink will provide comprehensive DSCSA capabilities for PharmaLink customers, enabling pharmacy dispensers to meet the regulatory...
read more
  • 1
  • …
  • 3
  • 4
  • 5
logotype

We strive to produce high quality conferences which include the latest topics which are delivered by world class leaders of the industry.

Facebook-fTwitterYoutubeLinkedin-inInstagramPinterest

Quick Links

About us
Contact us
Event Support
Careers
Privacy Policy
Terms & Conditions

Subscribe to our newsletter

    © 2025 Virtue Insight. All rights reserved.